Improving Healthcare for Incarcerated Women

Nijhawan AE , Salloway R , Nunn AS , Poshkus M , Clarke JG . Preventive healthcare for underserved women: Results of a prison survey. J Womens Health, 201019:this issue.

Walmsley R . World prison population list. Kings College of London InternationalCentre for Prison Studies, London, 2008.

Harrison P , Karberg J . Prison and jail inmates at midyear 2003. Justice USDo. Washington, DC: Bureau of Justice Statistics, 2004; 1–14.

Sabol W , Couture H . Prison inmates at midyear 2007. Bureau of Justice StatisticsUS Dept. of Justice, NCJ221944, 2008.

West HC , Sabol WJ . Prison inmates at midyear 2008—statistical tables. Bureau of Justice StatisticsUS Dept. of Justice, NCJ225619, 2009.

Mumola C , Karberg J . Drug use and dependence, state and federal prisonersUS Dept. of Justice, Office of Justice Programs, Washington, DC, 2006.

Nunn A , Zaller N , Dickman S , Trimbur C , Nijhawan A , Rich JD . Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug Alcohol Depend, 2009; 105:83–88Epub 2009, July 21.

The Pew Center on the States. One in 100: Behind Bars in America 2008. Washington, DC: The Pew Charitable TrustsFebruary, 2008.

Maruschak L , Beavers R . HIV in Prisons, 2007–2008Bureau of Justice Statistics Bulletin, Washington, DC. US Dept. of Justice, Office of Justice Programs, 2009http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=1747. 2010 January 7.

Baillargeon J , Binswanger IA , Penn JV , Williams BA , Murray OJ . Psychiatric disorders and repeat incarcerations: The revolving prison door. Am J Psychiatry, 2009; 166:103–109.

Peters RH , Greenbaum PE , Edens JF , Carter CR , Ortiz MM . Prevalence of DSM-IV substance abuse and dependence disorders among prison inmates. Am J Drug Alcohol Abuse, 1998; 24:573–587.

Reference deleted in proof.

Hammett TM , Harmon MP , Rhodes W . The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health, 2002; 92:1789–1794.

Maru DS , Bruce RD , Basu S , Altice FL . Clinical outcomes of hepatitis C treatment in a prison setting: Feasibility and effectiveness for challenging treatment populations. Clin Infect Dis, 2008; 47:952–961.

Springer S , Friedland G , Doros G , Pesanti E , Altice FL . Antiretroviral treatment regimen outcomes among HIV-infected prisoners. New Haven, CT: Yale AIDS Program, 2007.

Springer SA , Pesanti E , Hodges J , Macura T , Doros G , Altice FL . Effectiveness of antiretroviral therapy among HIV-infected prisoners: Reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis, 2004; 38:1754–1760.

Altice FL , Khoshnood K , Blankenship KM et al.Determinants of HIV seroprevalence and seroincidence of new entrants to a women's prison. Paper presented at XI International Conference on AIDS, Vancouver, Canada, 1996.

Altice FL , Marinovich A , Khoshnood K , Blankenship KM , Springer SA , Selwyn PA . Correlates of HIV infection among incarcerated women: Implications for improving detection of HIV infection. J Urban Health, 2005; 82:312–326.

Centers for Disease Control and Prevention. HIV prevalence estimates—United States, 2006. MMWR, 2008; 57:1073–1076.

Proca DM , Rofagha S , Keyhani-Rofagha S . High grade squamous intraepithelial lesion in inmates from Ohio: Cervical screening and biopsy follow-up. Cytojournal, 2006; 3:15.

Beck A , Karberg J , Harrison P . Prison and jail inmates at midyear 2001. U.S. Department of Justice. Bureau of Justice Statistics Bulletin, 2002.

Baillargeon J , Giordano TP , Rich JD et al. Accessing antiretroviral therapy following release from prison. JAMA, 2009; 301:848–857.

Stephenson BL , Wohl DA , Golin CE , Tien HC , Stewart P , Kaplan AH . Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep, 2005; 120:84–88.

Anderson RM , May RM . Epidemiological parameters of HIV transmission. Nature, 1988; 333:514–519.

Margolis AD , MacGowan RJ , Grinstead O , Sosman J , Kashif I , Flanigan TP . Unprotected sex with multiple partners: Implications for HIV prevention among young men with a history of incarceration. Sex Transm Dis, 2006; 33:175–180.

Stephenson BL , Wohl DA , McKaig R et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS, 2006; 17:103–108.

Branson BM , Handsfield HH , Lampe MA et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep, 2006; 55,RR-14:1–17.

Kinlock TW , Battjes RJ , Schwartz RP . A novel opioid maintenance program for prisoners: Preliminary findings. J Subst Abuse Treat, 2002; 22:141–147.

Kinlock TW , Gordon MS , Schwartz RP , O'Grady KE . A study of methadone maintenance for male prisoners: 3-Month postrelease outcomes. Crim Justice Behav, 2008; 35:34–47.

Wexler HK , Lipton D , Johnson BA . A criminal justice system strategy for treating cocaine-heroin abusing offenders in custody. US Dept. of Justice. Washington, DC, 1988.

Durand E . [Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996.] Ann Med Interne (Paris), 2001; 152,Suppl 7:9–14.

Sibbald B . Methadone maintenance expands inside federal prisons. Can Med Assoc J, 2002; 167:1154.

Byrne A , Dolan K . Methadone treatment is widely accepted in prisons in New South Wales. BMJ, 1998; 316:1744–1745.

Connock M , Juarez-Garcia A , Jowett S et al. Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technol Assess, 2007; 11:1–171iii–iv.

Garcia C , Correa G , Hernandez-Viver A et al. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addict Med, 2007; 1:126–132.

Amato L , Minozzi S , Davoli M , Vecchi S , Ferri MM , Mayet S . Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev, 2008CD005031.

Chandler RK , Fletcher BW , Volkow ND . Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. JAMA, 2009; 301:183–190.

Smith-Rohrberg D , Bruce RD , Altice FL . Review of corrections-based therapy for opiate-depenndent patients: Implications for buprenorphine treatment among correctional populations. J Drug Issues, 2004; 34:451–480.

Anton RF , O'Malley SS , Ciraulo DA et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA, 2006; 295:2003–2017.

Springer SA , Altice FL . Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep, 2005; 2:165–170.

Springer S , Altice F . Improving the care for HIV-infected prisoners: An integrated prison-release health model. Greifinger R . Public health behind bars: From prisons to communities. New York: Springer Science, 2007.

Morrissey JP , Steadman HJ , Dalton KM , Cuellar A , Stiles P , Cuddeback GS . Medicaid enrollment and mental health service use following release of jail detainees with severe mental illness. Psychiatr Serv, 2006; 57:809–815.

Morrissey JP , Dalton KM , Steadman HJ , Cuddeback GS , Haynes D , Cuellar A . Assessing gaps between policy and practice in Medicaid disenrollment of jail detainees with severe mental illness. Psychiatr Serv, 2006; 57:803–808.